Euroopa Liit - horvaadi - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Euroopa Liit - portugali - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Soome - soome - Fimea (Suomen lääkevirasto)

baxter oy - desflurane - inhalaatiohöyry, neste - 100 % - desfluraani

Euroopa Liit - kreeka - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Αντινεοπλασματικοί παράγοντες - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Soome - soome - Fimea (Suomen lääkevirasto)

baxter oy - sevoflurane - inhalaatiohöyry, neste - 100 % - sevofluraani

Soome - soome - Fimea (Suomen lääkevirasto)

baxter oy - glucose monohydrate - infuusioneste, liuos - 100 mg/ml - hiilihydraatit

Soome - soome - Fimea (Suomen lääkevirasto)

baxter oy - glucose monohydrate, sodium chloride - infuusioneste, liuos - 4.5 mg/ml + 25 mg/ml - elektrolyytit ja hiilihydraatit

Soome - soome - Fimea (Suomen lääkevirasto)

baxter oy - glucose monohydrate, sodium chloride - infuusioneste, liuos - 9 mg/ml + 50 mg/ml - elektrolyytit ja hiilihydraatit

Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

baxter holding b.v., the netherlands kobaltweg 49, 3542ce utrecht - propofol - inj.em.in (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ Η ΕΝΕΣΗ) - 10mg/ml - propofol 10mg - propofol

Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

baxter holding b.v., the netherlands kobaltweg 49, 3542ce utrecht - paracetamol - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 10mg/ml - paracetamol 10mg - paracetamol